Ximepime 500 mg/vial (IM/IV Injection)
500 mg vial: ৳ 300.00
Medicine Details
Category | Details |
---|---|
Generic | Cefepime hydrochloride |
Company | Globe pharmaceuticals ltd |
Also available as |
Title and Categories
- Ximepime
- Cephalosporin Antibiotic
- Fourth Generation Antibiotic
- Treatment for Pneumonia
- Treatment for Febrile Neutropenia
- Treatment for Urinary Tract Infections
- Treatment for Skin Infections
- Treatment for Intra-abdominal Infections
- Intravenous Administration
- Intramuscular Administration
- Pediatric Use
- Geriatric Use
- Pregnancy Category B
- Breastfeeding Caution
- Storage Conditions
Dimensions
- 500 mg (IV) vials
- 500 mg (IM) vials
- 1 gm (IV) vials
- 1 gm (IM) vials
- 2 gm (IV) vials
Color Options
Functions
- Bactericidal
- Mode of Action as Beta-lactam Antibiotic
- Disruption of Peptidoglycan Synthesis
- Empiric Therapy for Febrile Neutropenic Patients
Materials
- Cefepime
- Cephalosporins
- Microorganisms
- Peptidoglycan
- Penicillin Binding Proteins (PBPs)
Technical Specifications
- Administration Over 30 Minutes
- Dosage Adjustment for Renal Function
- Dose Adjustment for Pediatric Patients
- Compatibilities with IV Fluids
- Stability in Various Diluents
Design Elements
- Compatibility with IV Fluids and Diluents
- Overdose Symptoms
- Reconstitution Instructions
- Storage Expiry Date
Usability Features
- Intravenous Injection
- Intramuscular Injection
- Renal Function Monitoring
- Careful Observation for Overdose
- Supportive Treatment for Overdose
Mode of Action
- Bactericidal Activity
- Peptidoglycan Layer Disruption
- Transpeptidation Inhibition
Pharmacology
- Same Mode of Action as Other Beta-lactam Antibiotics
- Disruption of Peptidoglycan Layer
- Importance in Gram-positive Organisms
Dosage & Administration
- Duration for Various Infections
- Intravenous Dosage
- Intramuscular Dosage
- Empiric Therapy for Febrile Neutropenic Patients
- Dosage Adjustment Based on Infection Severity
- Caution for IM Route of Administration
Interaction
- Enhanced Nephrotoxicity with Aminoglycosides
- Nephrotoxicity with Potent Diuretics
Contraindications
- Hypersensitivity to Cefepime
- Hypersensitivity to Cephalosporin Class
- Hypersensitivity to Penicillin
- Hypersensitivity to Betalactum Antibiotics
Side Effects
Pregnancy & Lactation
- Pregnancy Category B
- Excretion in Breast Milk
- Caution for Nursing Women
Precautions & Warnings
- Prescribing in Absence of Bacterial Infection
- Risk of Drug-resistant Bacteria Development
- Prolonged Use Caution
- Prothrombin Activity Monitoring
- Caution in Gastrointestinal Disease
- Arginine Caution
Use in Special Populations
- Maximum Dose for Pediatric Patients
- Geriatric Adverse Events
- Renal Function Monitoring for Geriatric Patients
- Impaired Hepatic Function
- Impaired Renal Function
- Dose Adjustment for Impaired Renal Function
Overdose Effects
- Symptoms
- Supportive Treatment
- Renal Insufficiency Caution
Therapeutic Class
- Fourth Generation Cephalosporins
Reconstitution
- IV Administration
- IM Administration
- Compatibilities with IV Fluids
- Diluent Details
- Amount of WFI to be Added
- Approximate Available Volume
Storage Conditions
- Expiry Date
- Child Safety
- Prescription Requirement
Related Brands
- Ximepime 1 gm/vial (IM/IV Injection) - globe-pharmaceuticals-ltd
- Magnova 500 mg/vial (IM/IV Injection) - orion-pharma-ltd
- Magnova 1 gm/vial (IM/IV Injection) - orion-pharma-ltd
- Superpime 1 gm/vial (IM/IV Injection) - acme-laboratories-ltd
- Superpime 500 mg/vial (IM/IV Injection) - acme-laboratories-ltd